All Type of News
Hanmi to co-market GSK’s three medicines
Hanmi Pharm and GlaxoSmithKline announced on May 8 that the two companies have signed a strategic alliance agreement to co-promote Seretide (fluticasone + salmetelol), Avamys (fluticasone furoate) and Flixonase (fluti...
Drug wholesalers facing survival game
Worries have arisen in the domestic wholesaling industry that drug wholesalers might be lose its competitiveness in the midst of some foreign-invested pharmaceutical firms’ pressure to reduce the margin, shorten the t...
KFDA warns adverse events of botulinum toxin products
Prompted by the U.S. Food and Drug Administration’s reports of serious adverse events associated with botulinum toxin products, the Korea Food and Drug Administration said that a stricter label warning is necessary fo...
101 patients visit ENT clinics daily in 2008
Over 101 patients visited an ENT (ear, nose and throat) clinic a day last year, while an orthopedist and a pediatrician saw a respective 94 and 85 patients each a day, according to a report by the National Health Insu...
Government urged to boost domestic pharmaceutical industry
The local pharmaceutical industry is expected to be the one of the most competitive markets and a next generation cash cow if the government works out measures to support research activities for the development of inn...
Government to ease service-sector regulation for competitiveness
The government plans to ease regulations and expand support for the service sector as part of efforts to enhance its competitiveness and fuel overall economic growth, according to the Ministry of Health, Welfare and F...
Essential drugs should be marketed at supermarkets, the KMA says
The Korean Medical Association is arguing that the government will have to allow some essential drugs, such as digestives, to be sold at supermarkets.
“It will be nicer for consumers to have easy access to the pill...
Levovir likely to remarketed this week
The Food and Drug Administration will announce a plan to allow the re-sales of Levovir (clevudine) sooner or later, as the Central Pharmaceutical Affairs Review Committee made a final conclusion on May 7 that its risk...
Dongkook struggles to reverse decline in Insadol sales
Dongkook Pharm has strived to boost the sluggish sales of Insadol, a top-selling OCT medicine for treatment of gingival disease, by providing better wholesaler’s margin.
The company is hoping to find sales-boosting...
Government pressed to develop vaccine for H1N1 influenza
As many governments including Korea are rushing to stockpile Tamiflu drugs amid public concerns over H1N1 influenza, experts said the Korean government should focus on developing a vaccine for the disease.
“Tamif...
